Compare XCUR & SVRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XCUR | SVRN |
|---|---|---|
| Founded | 2011 | 2021 |
| Country | United States | Greece |
| Employees | N/A | 87 |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7M | 11.7M |
| IPO Year | 2017 | N/A |
| Metric | XCUR | SVRN |
|---|---|---|
| Price | $1.30 | $6.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 234.6K | 8.4K |
| Earning Date | 03-25-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.30 | $0.16 |
| 52 Week High | $9.48 | $15.07 |
| Indicator | XCUR | SVRN |
|---|---|---|
| Relative Strength Index (RSI) | 28.76 | 35.18 |
| Support Level | N/A | $5.32 |
| Resistance Level | $2.02 | $8.82 |
| Average True Range (ATR) | 0.18 | 0.62 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 6.95 | 9.54 |
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.